(Date:12/16/2009)... -- Eppendorf has initiated an,import ban for ... for,infringement of European patent EP 1 179 ... the quantification of a target compound". The ... the respective products into any country of,the ... confiscate any,violating products. , ...
(Date:12/15/2009)... Repligen Corporation (Nasdaq: RGEN ) ... in research funding to support the ongoing development ... Muscular Dystrophy Association (MDA). This grant will ... and GMP manufacture of a drug candidate for ... not only provides important funding for Repligen,s research ...
(Date:12/15/2009)... for Atomic Force Microscopy (AFM) have been developed and ... at the liquid/air interface. The NeedleProbes’ cylindrical geometry enables ... rate and viscosity - all in a single force distance ... ... 2009 -- New, constant diameter NeedleProbes are enabling ...
(Date:12/15/2009)... -- Thomson Reuters today ... the first drug pipeline database to fully integrate ... highly anticipated new content is being provided to ... ,, Thomson Pharma will offer drug ... releases, conferences, and other sources across all therapeutic ...
Breaking Biology Technology:Eppendorf Successfully Initiates Import ban Against Nanosphere, Inc. for the Countries of the European Union 2Repligen Receives Second Research Grant from the Muscular Dystrophy Association to Support Friedreich's Ataxia Preclinical Development Program 2Repligen Receives Second Research Grant from the Muscular Dystrophy Association to Support Friedreich's Ataxia Preclinical Development Program 3New Constant Diameter NeedleProbes™ with Unique Ability to Measure Liquid Surface Properties by AFM 2New Constant Diameter NeedleProbes™ with Unique Ability to Measure Liquid Surface Properties by AFM 3Thomson Reuters is First to Offer Fully Integrated Pipeline and Clinical Trials 2... RAMON, Calif., Aug. 7 Odyssey Thera, Inc. ... Pfizer Inc, following,Pfizer,s decision to progress a discovery ... was extensively studied by,Odyssey Thera as part of ... very pleased with the progress of the collaboration ...
... PASADENA, Calif., Aug. 7 AutoImmune Inc. (OTC,Pink Sheets: AIMM) ... share,basic and diluted, for the three months ended June 30, ... per share basic and diluted, for the,three months ended June ... net loss was $193,000, or $0.01 per share basic and ...
... KERX ) will hold a conference call on ... the second quarter 2008 financial results.,Michael S. Weiss, Chairman ... call. Keryx will announce its financial results for this ... the call., In order to participate in the ...
Other Biology Technology:AutoImmune Inc. Reports 2008 Second Quarter Financial Results 2AutoImmune Inc. Reports 2008 Second Quarter Financial Results 3Keryx Biopharmaceuticals, Inc. to Hold Conference Call on Second Quarter 2008 Financial Results on Monday, August 11, at 8:30 A.M. EDT 2... need to breathe. Prior to being born we carry this ... our lungs. In normal development, the lungs of the foetus ... first cry activates this respiration surface. But the main problem ... well formed. Moreover, they often lack surfactant, a compound formed ...
... a cellular mechanism that may help explain the puzzle ... to tuberculosis infection and why, once infected, they develop ... team includes researchers from University of California, Los Angeles ... paper will appear online in the February 23 issue ...
... scientists have found that people have an ancient skeleton ... a jawless, eel-like fish. , It turns out lampreys, ... than almost all other backboned animals, may not be ... genetics that govern their skeletal development, according to findings ...
Other Biology News:Liquid ventilation 2Newly identified mechanism helps explain why people of African descent are more vulnerable to TB 2Newly identified mechanism helps explain why people of African descent are more vulnerable to TB 3UF scientists reveal ancient origin of vertebrate skeleton 2UF scientists reveal ancient origin of vertebrate skeleton 3Biology NavigationMedical Navigation